Reply To: Cognitive Effects of Deep Brain Stimulation in GBA-Related Parkinson's Disease
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Genetic testing for Parkinson's disease in clinical practice.
Gasser T J Neural Transm (Vienna). 2023; 130(6):777-782.
PMID: 36929227 PMC: 10199829. DOI: 10.1007/s00702-023-02612-x.
References
1.
DAgostino Jr R
. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med. 1998; 17(19):2265-81.
DOI: 10.1002/(sici)1097-0258(19981015)17:19<2265::aid-sim918>3.0.co;2-b.
View
2.
Almaghlouth I, Pullenayegum E, Gladman D, Urowitz M, Johnson S
. Propensity Score Methods in Rare Disease: A Demonstration Using Observational Data in Systemic Lupus Erythematosus. J Rheumatol. 2020; 48(3):321-325.
DOI: 10.3899/jrheum.200254.
View
3.
Salles P, Mata I, Fernandez H
. Should we start integrating genetic data in decision-making on device-aided therapies in Parkinson disease? A point of view. Parkinsonism Relat Disord. 2021; 88:51-57.
DOI: 10.1016/j.parkreldis.2021.05.013.
View
4.
Weill C, Gallant A, Lintsky E, Dienstag A, Israel Z, Arkadir D
. Cognitive Effects of Deep Brain Stimulation in GBA-Related Parkinson Disease. Ann Neurol. 2022; 92(2):344-345.
DOI: 10.1002/ana.26432.
View
5.
. The Parkinson Progression Marker Initiative (PPMI). Prog Neurobiol. 2011; 95(4):629-35.
PMC: 9014725.
DOI: 10.1016/j.pneurobio.2011.09.005.
View